Over the weekend we reported that the Philippines, one of four countries to approve the Sanofi Pasteur  dengue vaccine, Dengvaxia, and the first in Asia, were to commence the first dengue vaccine campaign...

After reporting in excess of 200,000 dengue fever cases and nearly 600 deaths in 2015 and seeing nearly 20,000 cases through Feb. 20 of this year, Philippine health officials are ready to kick off the...

The Philippines Food and Drug Administration (FDA) announced the recall of the anti-tuberculosis drug, Onecure, after one component of the drug failed specifications. Onecure, which is manufactured by...

Following recent reports of an American contracting Zika virus infection while in the Philippines, The Department of Health (DOH) said they expect the US Centers for Disease Control and Prevention (CDC)...

March is Rabies Awareness Month each year in the Philippines where animal bites and the deadly virus is a serious issue. In 2015, a total of 432,458 animal bite cases were recorded by the Philippines...

The number of dengue fever cases in the Philippines increased by nearly 6000 as the country of some 7000 islands reported 18,790 suspected cases of dengue as of Feb. 20, up from 12,904 suspected cases...

By

Between 1 January 2007 and 9 March 2016, a total of 52 countries and territories have reported autochthonous (local) transmission or indication of transmission of Zika virus (41 since 1 January 2015)....

An unidentified American woman has reportedly contracted Zika virus while staying in the Philippines in January, according to local media reports. In a press briefing Sunday, Philippines Health Secretary...

After reporting more than 200,000 dengue fever cases and 600 deaths during 2015, the Philippines has recorded nearly 13,000 cases during the first five weeks of this year, according to the latest data...

Sanofi Pasteur’s first on the market dengue fever vaccine, Dengvaxia, was first approved by the Philippines Food and Drug Administration (FDA) in December, the first country in Asia to do so and...